Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
2.270
+0.040 (1.79%)
At close: Dec 5, 2025, 4:00 PM EST
2.140
-0.130 (-5.73%)
After-hours: Dec 5, 2025, 7:31 PM EST
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $156.55 million as of December 5, 2025. Its market cap has increased by 461.36% in one year.
Market Cap
156.55M
Enterprise Value
127.49M
1-Year Change
461.36%
Ranking
Category
Stock Price
$2.27
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $156.55M, an increase of 636.27%. That is a compound annual growth rate of 48.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 156.55M | 316.72% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | 70.36M | 230.93% |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |